世界のマイクロバイオーム治療薬市場は、2021年に約921億5,000万米ドルと評価され、予測期間の2022年から2029年には35.32%以上の健全な成長率で成長すると予測されています。マイクロバイオーム治療薬は、ネイティブ（天然）または合成の細菌、抗生物質、バクテリオファージ、バクテリオシンを添加療法、減算療法、調節療法に適用することにより、腸内細菌叢を工学的に制御することすることを目的としています。市場は、マイクロバイオーム治療分野における研究開発、製品開拓、ポートフォリオ拡大のための戦略的パートナーシップの増加などの要因によって拡大しています。開発中の治療薬のほとんどは、まだ初期段階であり、通常、第I相と第II相の間です。23のうち、13以上の医薬品が消化器系を適応症として研究されており、その大半は潰瘍性大腸炎に焦点をあてています。例えば、Seres Therapeutics, Inc.社は、2021年に第3相ECOSPOR III試験のSER-109の試験結果を開示しました。再発性クロストリジウム・ディフィシル（C.difficile）感染症の経口治療薬として、2023年前半にパイプライン医薬品を導入する予定です。SER-109は、プラセボと比較して、抗菌薬耐性遺伝子の減少につながります。また、2022年1月にハドソン研究所とバイオメバンクの間で、微生物医薬品の開発・発見のための4年間のパートナーシップを確立しました。
対象疾患の増加に伴い、マイクロバイオーム治療薬の需要も高まっています。マイクロバイオーム研究の発展は、感染症やその他の病気に対してより効果的な治療法を探し、医療治療の成果を向上させると予想されます。企業は商品のコストを下げ、より多くの人々が最先端のヘルスケアにアクセスできるようになり、一部の国の行政当局はマイクロバイオームベースの治療法の採用を支援するために戦略を変えています。その結果、市場ベンダーは市場シェアを拡大するための有利な成長機会を得ることができます。マイクロバイオーム治療の高コストと、製品の複雑さがもたらす厳しい規制ルールが、市場の拡大を制限する2つの主要な課題となっています。
世界のマイクロバイオーム治療薬市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、および世界のその他の地域含まれます。2021年に最大の市場シェアを獲得した北アメリカは、業界を支配しています。この地域の優位性は、革新的な治療法を生み出すための研究能力が確立されていることと、対象人口が拡大していることが主な原因です。また、カナダではカナダマイクロバイオームイニシアチブ（Canadian Microbiome Initiative : CMI）のような取り組みが偏在しているため、パートナーや利害関係者との連携が容易になっています。そのため、微生物医薬品の創製に研究努力を集中させることが可能になっています。例えば、Biocodex Microbiota Foundationは2021年7月、カナダで総額26,000米ドル以上のマイクロバイオーム研究資金を提供するための募集要項を発表しました。これらのインセンティブにより、新たな市場のイノベーションが促進されると予想されます。アジア太平洋は、老年人口や対象人口の増加、バイオシミラー開拓のための共同研究件数の増加、主要参入企業の地理的拡大、政府機関や非営利団体の市場空間への積極的参加などの要因から、予測期間中に大きく成長すると予測されています。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Microbiome Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Microbiome Therapeutics Market, by Type, 2019-2029 (USD Billion)
1.2.3. Microbiome Therapeutics Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Microbiome Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Microbiome Therapeutics Market Dynamics
3.1. Microbiome Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing number of strategic collaborations for microbiome therapeutics for R&D
3.1.1.2. Increase in the prevalence of target diseases.
3.1.2. Market Challenges
3.1.2.1. High Cost of Microbiome Therapeutics
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
Chapter 4. Global Microbiome Therapeutics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Microbiome Therapeutics Market, by Type
6.1. Market Snapshot
6.2. Global Microbiome Therapeutics Market by Type, Performance - Potential Analysis
6.3. Global Microbiome Therapeutics Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Microbiome Therapeutics Market, Sub Segment Analysis
6.4.1. FMT
6.4.2. Microbiome Drugs
Chapter 7. Global Microbiome Therapeutics Market, by Application
7.1. Market Snapshot
7.2. Global Microbiome Therapeutics Market by Application, Performance - Potential Analysis
7.3. Global Microbiome Therapeutics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Microbiome Therapeutics Market, Sub Segment Analysis
7.4.1. C. difficile
7.4.2. Crohn's Disease
7.4.3. Inflammatory Bowel Disease
7.4.4. Diabetes
7.4.5. Others
Chapter 8. Global Microbiome Therapeutics Market, Regional Analysis
8.1. Microbiome Therapeutics Market, Regional Market Snapshot
8.2. North America Microbiome Therapeutics Market
8.2.1. U.S. Microbiome Therapeutics Market
8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Microbiome Therapeutics Market
8.3. Europe Microbiome Therapeutics Market Snapshot
8.3.1. U.K. Microbiome Therapeutics Market
8.3.2. Germany Microbiome Therapeutics Market
8.3.3. France Microbiome Therapeutics Market
8.3.4. Spain Microbiome Therapeutics Market
8.3.5. Italy Microbiome Therapeutics Market
8.3.6. Rest of Europe Microbiome Therapeutics Market
8.4. Asia-Pacific Microbiome Therapeutics Market Snapshot
8.4.1. China Microbiome Therapeutics Market
8.4.2. India Microbiome Therapeutics Market
8.4.3. Japan Microbiome Therapeutics Market
8.4.4. Australia Microbiome Therapeutics Market
8.4.5. South Korea Microbiome Therapeutics Market
8.4.6. Rest of Asia Pacific Microbiome Therapeutics Market
8.5. Latin America Microbiome Therapeutics Market Snapshot
8.5.1. Brazil Microbiome Therapeutics Market
8.5.2. Mexico Microbiome Therapeutics Market
8.6. Rest of The World Microbiome Therapeutics Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. OpenBiome
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Seres Therapeutics Inc.
9.2.3. 4D Pharma plc.
9.2.4. Locus Biosciences, Inc.
9.2.5. Enterome SA
9.2.6. Finch Therapeutics Group, Inc.
9.2.7. Intralytix, Inc.
9.2.8. Microbiotica
9.2.9. Second Genome
9.2.10. Rebiotix Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Microbiome Therapeutics Market, report scope
TABLE 2. Global Microbiome Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Microbiome Therapeutics Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Microbiome Therapeutics Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Microbiome Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Microbiome Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Microbiome Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Microbiome Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Microbiome Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Microbiome Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Microbiome Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Microbiome Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Microbiome Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Microbiome Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Microbiome Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Microbiome Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Microbiome Therapeutics Market
TABLE 70. List of primary sources, used in the study of global Microbiome Therapeutics Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Microbiome Therapeutics Market, research methodology
FIG 2. Global Microbiome Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Microbiome Therapeutics Market, key trends 2021
FIG 5. Global Microbiome Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Microbiome Therapeutics Market, porters 5 force model
FIG 7. Global Microbiome Therapeutics Market, pest analysis
FIG 8. Global Microbiome Therapeutics Market, value chain analysis
FIG 9. Global Microbiome Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Microbiome Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Microbiome Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Microbiome Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Microbiome Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Microbiome Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Microbiome Therapeutics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Microbiome Therapeutics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Microbiome Therapeutics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Microbiome Therapeutics Market 2019 & 2029 (USD Billion)
FIG 19. Global Microbiome Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
